Cost effectiveness of ACE inhibitor treatment for patients with type 1 diabetes mellitus.
Dong FB, Sorensen SW, Manninen DL, Thompson TJ, Narayan V, Orians CE, Gregg EW, Eastman RC, Dasbach EJ, Herman WH, Newman JM, Narva AS, Ballard DJ, Engelgau MM.
Dong FB, et al. Among authors: newman jm.
Pharmacoeconomics. 2004;22(15):1015-27. doi: 10.2165/00019053-200422150-00005.
Pharmacoeconomics. 2004.
PMID: 15449965